Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-20 1:00 pm Purchase | 13G | BIOFRONTERA INC BFRI | LYTTON LAURENCE W | 508,886 9.99% | 508,886 (New Position) | View |
| 2024-03-13 1:32 pm Purchase | 13G | EVOKE PHARMA INC EVOK | LYTTON LAURENCE W | 859,322 9.99% | 859,322 (New Position) | View |
| 2024-02-27 2:05 pm Purchase | 13G | AZITRA INC AZTR | LYTTON LAURENCE W | 1,666,600 5.8% | 1,666,600 (New Position) | View |
| 2024-02-14 6:48 pm Sale | 13G | TFF PHARMACEUTICALS INC TFFP | LYTTON LAURENCE W | 11,900 0.1% | -3,113,822 (-99.62%) | View |
| 2024-02-14 3:28 pm Purchase | 13G | SCIENTIFIC INDUSTRIES INC SCND | LYTTON LAURENCE W | 1,083,899 9.99% | 689,220 (+174.63%) | View |
| 2024-02-14 3:23 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | LYTTON LAURENCE W | 3,280,178 9.99% | 1,395,105 (+74.01%) | View |
| 2024-02-14 2:42 pm Purchase | 13G | EXAGEN INC XGN | LYTTON LAURENCE W | 1,153,488 6.8% | 282,307 (+32.41%) | View |
| 2024-02-14 2:35 pm Purchase | 13G | STRYVE FOODS INC SNAX | LYTTON LAURENCE W | 194,780 8.9% | 194,780 (New Position) | View |
| 2024-02-14 2:27 pm Purchase | 13G | SOCIETAL CDMO INC SCTL | LYTTON LAURENCE W | 10,340,858 9.9% | 3,847,168 (+59.24%) | View |
| 2024-02-14 2:22 pm Sale | 13G | RAIL VISION LTD SHARE RVSN | LYTTON LAURENCE W | 450,000 9.3% | -1,130,000 (-71.52%) | View |
| 2024-02-14 2:09 pm Purchase | 13G | RINGCENTRAL INC RNG | LYTTON LAURENCE W | 1,528,157 1.8% | 1,528,157 (New Position) | View |
| 2024-02-14 2:03 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | LYTTON LAURENCE W | 232,951 4.3% | 232,951 (New Position) | View |
| 2024-02-14 1:59 pm Sale | 13G | MIROMATRIX MEDICAL INC. MIRO | LYTTON LAURENCE W | 0 0% | -1,380,367 (Position Closed) | View |
| 2024-02-14 1:49 pm Purchase | 13G | LIQTECH INTL INC PAR $0.00 LIQT | LYTTON LAURENCE W | 589,653 9.99% | 589,653 (New Position) | View |
| 2024-02-14 1:43 pm Sale | 13G | ATYR PHARMA INC LIFE | LYTTON LAURENCE W | 585,013 1% | -3,855,175 (-86.82%) | View |
| 2024-02-14 1:36 pm Purchase | 13G | GIGA-TRONICS INC GIGA | LYTTON LAURENCE W | 608,177 9.99% | 4,477 (+0.74%) | View |
| 2024-02-14 1:31 pm Purchase | 13G | EMCORE CORP EMKR | LYTTON LAURENCE W | 7,787,328 9.99% | 4,864,057 (+166.39%) | View |
| 2024-02-14 1:23 pm Sale | 13G | DUOS TECHNOLOGIES GROUP INC DUOT | LYTTON LAURENCE W | 482,976 6.7% | -151,049 (-23.82%) | View |
| 2024-02-14 1:18 pm Unchanged | 13G | GYRE THERAPEUTICS INC GYRE | LYTTON LAURENCE W | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 1:10 pm Purchase | 13G | BIOLASE INC PAR $.001 BIOL | LYTTON LAURENCE W | 26,824 0.6% | 26,824 (New Position) | View |